These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 20634005)
1. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005 [TBL] [Abstract][Full Text] [Related]
2. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238 [TBL] [Abstract][Full Text] [Related]
3. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
4. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Steinman S; Wang J; Bourne P; Yang Q; Tang P Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma. Zheng WQ; Looi LM; Cheah PL Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218 [TBL] [Abstract][Full Text] [Related]
7. Expression of manganese superoxide dismutase in patients with breast cancer. Tsai SM; Hou MF; Wu SH; Hu BW; Yang SF; Chen WT; Chai CY; Ma H; Tsai LY Kaohsiung J Med Sci; 2011 May; 27(5):167-72. PubMed ID: 21527182 [TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
9. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
10. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related]
11. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component. Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943 [TBL] [Abstract][Full Text] [Related]
12. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast. Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761 [TBL] [Abstract][Full Text] [Related]
13. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade. Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189 [TBL] [Abstract][Full Text] [Related]
14. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast. Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076 [TBL] [Abstract][Full Text] [Related]
15. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Logullo AF; Nonogaki S; Pasini FS; Osório CA; Soares FA; Brentani MM Oncol Rep; 2010 Feb; 23(2):313-20. PubMed ID: 20043090 [TBL] [Abstract][Full Text] [Related]
16. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Park K; Han S; Kim HJ; Kim J; Shin E Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma]. Wang SY; Peng DF; Cai ZG; Zhang RZ; Yao TJ; Zhang H; Yang M; Dong HM Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937 [TBL] [Abstract][Full Text] [Related]
18. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence. Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729 [TBL] [Abstract][Full Text] [Related]
19. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916 [TBL] [Abstract][Full Text] [Related]
20. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hanley K; Wang J; Bourne P; Yang Q; Gao AC; Lyman G; Tang P Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]